Hemodynamic monitoring company LiDCO Group booked an annual loss, as the transition to a new business model and Brexit uncertainty hit sales.
Pre-tax losses for the year through January amounted to £2.1m, compared to losses of £2.2m on-year.
Revenue fell 11%, partly pinned on the adoption of a high usage programme, or HUP, business model.
'We continue to make good progress with the transition and it's pleasing to see a further 48 HUP monitors signed since the year end,' chief executive Matthew Sassone said.
'Since launching HUP in mid-2017 we have built a recurring revenue base from HUP of over £1.8m.'
'The growing base of HUP monitors and the underlying fundamentals of the business positions the company for strong growth in the current financial year and beyond.'
At 2:36pm: (LON:LID) LiDCO Group PLC share price was +0.5p at 4.55p